Wolverine Trading
INMB icon

Wolverine Trading’s INmune Bio INMB Stock Holding History

Wolverine Trading’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$61.6K Buy
+29,193
New +$66.8K ﹤0.01% 5364
2025
Q2 		– Sell
-19,392
Closed -$146K – 5147
2025
Q1 		$146K Buy
+19,392
New +$154K ﹤0.01% 4098

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wolverine Trading's INMB Position: Q3 2025 in Review

Wolverine Trading opened a new position in INmune Bio (INMB) in Q3 2025: 29,193 shares worth $61.6K. The stake represents ﹤0.01% of the portfolio and ranks #5364 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in INMB as recently as Q1 2025.

Wolverine Trading first reported a position in INMB in Q1 2025 and has held it in 2 quarters since. The position peaked at $146K in Q1 2025. 73 funds tracked by Wall St. Rank hold INMB as of Q3 2025.

  • Wolverine Trading held 29,193 shares of INmune Bio worth $61.6K as of Q3 2025.
  • INmune Bio was a new Wolverine Trading position in Q3 2025.
  • INmune Bio made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5364 holding.
  • Wolverine Trading first reported a position in INmune Bio in Q1 2025 and has held it in 2 quarters since.
  • Wolverine Trading's INmune Bio position peaked at $146K in Q1 2025.
  • 73 funds tracked by Wall St. Rank held INmune Bio as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.